PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis. (Q64955321)
Jump to navigation
Jump to search
scientific article published on 29 October 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis. |
scientific article published on 29 October 2018 |
Statements
PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis. (English)
1 reference
Youjeong Seo
1 reference
Yeon Hee Park
1 reference
Jin Seok Ahn
1 reference
Young-Hyuck Im
1 reference
Seok Jin Nam
1 reference
Soo Youn Cho
1 reference
Eun Yoon Cho
1 reference
29 October 2018
1 reference
21
1 reference
4
1 reference
382-390
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference